NEW YORK, Feb. 15, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of USANA Health Sciences, Inc. ("USANA") (NYSE:USNA) between March 14, 2014 and February 7, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Utah. To get more information go to:
http://www.zlk.com/pslra/usana-health-sciences-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts, including that: (i) the Company's BabyCare Ltd. subsidiary had engaged in improper reimbursement practices in China; (ii) these practices constituted violations of the Foreign Corrupt Practices Act; (iii) as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (iv) the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and (v) as a result of the foregoing, USANA’s public statements were materially false and misleading at all relevant times
On February 7, 2017, post-market, USANA disclosed that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies.”
If you suffered a loss in USANA you have until April 14, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 



